77 related articles for article (PubMed ID: 24624986)
21. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Rassidakis GZ; Medeiros LJ; Viviani S; Bonfante V; Nadali GP; Vassilakopoulos TP; Mesina O; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McLaughlin P; Rodriguez MA; Romaguera J; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
J Clin Oncol; 2002 Mar; 20(5):1278-87. PubMed ID: 11870170
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
[TBL] [Abstract][Full Text] [Related]
23. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
24. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.
Bhargava P; Pantanowitz L; Pinkus GS; Pinkus JL; Paessler ME; Roullet M; Gautam S; Bagg A; Kadin ME
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):16-23. PubMed ID: 19550297
[TBL] [Abstract][Full Text] [Related]
25. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
[TBL] [Abstract][Full Text] [Related]
26. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
27. Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).
Gorde-Grosjean S; Oberlin O; Leblanc T; Pacquement H; Donadieu J; Lambilliotte A; Schell M; Dommange F; Munzer M; Paillard C; Schmitt C; Lutz P; Edan C; Ansoborlo S; Stephan JL; Michel G; Thomas C; Perel Y; Robert A; Landman-Parker J
Br J Haematol; 2012 Sep; 158(5):649-56. PubMed ID: 22757721
[TBL] [Abstract][Full Text] [Related]
28. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
[TBL] [Abstract][Full Text] [Related]
29. CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphoma.
Koh YW; Park C; Yoon DH; Suh C; Huh J
Am J Clin Pathol; 2014 Apr; 141(4):573-83. PubMed ID: 24619759
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of procaspase-3 and its clinical significance in childhood non-Hodgkin lymphomas.
Wrobel G; Maldyk J; Kazanowska B; Rapala M; Maciejka-Kapuscinska L; Chaber R
Pediatr Dev Pathol; 2011; 14(3):173-9. PubMed ID: 20722551
[TBL] [Abstract][Full Text] [Related]
31. Cellular Senescence Markers p16INK4a and p21CIP1/WAF Are Predictors of Hodgkin Lymphoma Outcome.
Caliò A; Zamò A; Ponzoni M; Zanolin ME; Ferreri AJ; Pedron S; Montagna L; Parolini C; Fraifeld VE; Wolfson M; Yanai H; Pizzolo G; Doglioni C; Vinante F; Chilosi M
Clin Cancer Res; 2015 Nov; 21(22):5164-72. PubMed ID: 26199387
[TBL] [Abstract][Full Text] [Related]
32. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
[TBL] [Abstract][Full Text] [Related]
33. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
Dinand V; Malik A; Unni R; Arya LS; Pandey RM; Dawar R
Pediatr Blood Cancer; 2008 Feb; 50(2):280-3. PubMed ID: 17417795
[TBL] [Abstract][Full Text] [Related]
34. Low apoptotic index & bak expression in EBV-associated childhood classical Hodgkin lymphoma.
Dinand V; Malik A; Mohanty B; Chander B; Arya LS; Dawar R
Indian J Med Res; 2009 Nov; 130(5):526-32. PubMed ID: 20090100
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
37. Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma.
Fernández-Vega I; Quirós LM; Santos-Juanes J; Pane-Foix M; Marafioti T
Virchows Arch; 2015 Feb; 466(2):229-35. PubMed ID: 25433814
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.
Tzankov A; Krugmann J; Fend F; Fischhofer M; Greil R; Dirnhofer S
Clin Cancer Res; 2003 Apr; 9(4):1381-6. PubMed ID: 12684408
[TBL] [Abstract][Full Text] [Related]
39. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
[TBL] [Abstract][Full Text] [Related]
40. [Expression of fragile histidine triad (FHIT) protein and its significance in diagnosing classical Hodgkin lymphoma].
Zhao P; Lü YL; Zhong M; Chen LH; Pu XL
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):289-91. PubMed ID: 16777001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
